Relationships of Prodiginins Mechanisms and Molecular Structures to Their Antiproliferative Effects

Overview

Journal Anticancer Agents Med Chem

Publisher Bentham Science Publishers

Specialties Chemistry
Oncology

Date 2024 Aug 8

PMID 39113301

Authors

El Abbassi Ayoub

Zineb Azoubi

Zougagh Nadia

Mouslim Assia

Menggad Mohammed

Affiliations

Soon will be listed here.

Abstract

The Prodiginins (PGs) natural pigments are secondary metabolites produced by a broad spectrum of gram-negative and gram-positive bacteria, notably by species within the Serratia and Streptomyces genera. These compounds exhibit diverse and potent biological activities, including anticancer, immunosuppressive, antimicrobial, antimalarial, and antiviral effects. Structurally, PGs share a common tripyrrolic core but possess variable side chains and undergo cyclization, resulting in structural diversity. Studies have investigated their antiproliferative effects on various cancer cell lines, with some PGs advancing to clinical trials for cancer treatment. This review aims to illuminate the molecular mechanisms underlying PG-induced apoptosis in cancer cells and explore the structure-activity relationships pertinent to their anticancer properties. Such insights may serve as a foundation for further research in anticancer drug development, potentially leading to the creation of novel, targeted therapies based on PGs or their derivatives.

References

Williamson N, Fineran P, Leeper F, Salmond G . The biosynthesis and regulation of bacterial prodiginines. Nat Rev Microbiol. 2006; 4(12):887-99. DOI: 10.1038/nrmicro1531. View

Ullah A, Ullah N, Nawaz T, Aziz T . Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment. Anticancer Agents Med Chem. 2022; 23(7):765-778. DOI: 10.2174/1871520622666220831124321. View

Ullah A, Razzaq A, Alfaifi M, Elbehairi S, Menaa F, Ullah N . Sanguinarine Attenuates Lung Cancer Progression via Oxidative Stress-induced Cell Apoptosis. Curr Mol Pharmacol. 2024; 17:e18761429269383. DOI: 10.2174/0118761429269383231119062233. View

Wang Z, Li B, Zhou L, Yu S, Su Z, Song J . Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells. Proc Natl Acad Sci U S A. 2016; 113(46):13150-13155. PMC: 5135380. DOI: 10.1073/pnas.1616336113. View

Kapoor R, Saini A, Sharma D . Indispensable role of microbes in anticancer drugs and discovery trends. Appl Microbiol Biotechnol. 2022; 106(13-16):4885-4906. DOI: 10.1007/s00253-022-12046-2. View

Law J, Law L, Letchumanan V, Tan L, Wong S, Chan K . Anticancer Drug Discovery from Microbial Sources: The Unique Mangrove Streptomycetes. Molecules. 2020; 25(22). PMC: 7698459. DOI: 10.3390/molecules25225365. View

Baindara P, Mandal S . Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics. Biochimie. 2020; 177:164-189. DOI: 10.1016/j.biochi.2020.07.020. View

Rivankar S . An overview of doxorubicin formulations in cancer therapy. J Cancer Res Ther. 2015; 10(4):853-8. DOI: 10.4103/0973-1482.139267. View

Takeuchi T . Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry. J Cancer Res Clin Oncol. 1995; 121(9-10):505-10. DOI: 10.1007/BF01197761. View

10.

Ramos A, Sadeghi S, Tabatabaeian H . Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them. Int J Mol Sci. 2021; 22(17). PMC: 8430957. DOI: 10.3390/ijms22179451. View

11.

Lazaro J, Nitcheu J, Predicala R, Mangalindan G, Nesslany F, Marzin D . Heptyl prodigiosin, a bacterial metabolite, is antimalarial in vivo and non-mutagenic in vitro. J Nat Toxins. 2002; 11(4):367-77. View

12.

Yip C, Mahalingam S, Wan K, Nathan S . Prodigiosin inhibits bacterial growth and virulence factors as a potential physiological response to interspecies competition. PLoS One. 2021; 16(6):e0253445. PMC: 8221495. DOI: 10.1371/journal.pone.0253445. View

13.

Han S, Kim H, Kim Y, Lee C, Jang E, Son K . T-cell specific immunosuppression by prodigiosin isolated from Serratia marcescens. Int J Immunopharmacol. 1998; 20(1-3):1-13. DOI: 10.1016/s0192-0561(97)00062-3. View

14.

Darshan N, Manonmani H . Prodigiosin and its potential applications. J Food Sci Technol. 2015; 52(9):5393-407. PMC: 4554646. DOI: 10.1007/s13197-015-1740-4. View

15.

Hu D, Withall D, Challis G, Thomson R . Structure, Chemical Synthesis, and Biosynthesis of Prodiginine Natural Products. Chem Rev. 2016; 116(14):7818-53. PMC: 5555159. DOI: 10.1021/acs.chemrev.6b00024. View

16.

Kim D, Lee J, Park Y, Kim J, Jeong H, Oh T . Biosynthesis of antibiotic prodiginines in the marine bacterium Hahella chejuensis KCTC 2396. J Appl Microbiol. 2007; 102(4):937-44. DOI: 10.1111/j.1365-2672.2006.03172.x. View

17.

Lee J, Kim Y, Park S, Kim J, Kang S, Lee M . Exceptional production of both prodigiosin and cycloprodigiosin as major metabolic constituents by a novel marine bacterium, Zooshikella rubidus S1-1. Appl Environ Microbiol. 2011; 77(14):4967-73. PMC: 3147376. DOI: 10.1128/AEM.01986-10. View

18.

Cerdeno A, Bibb M, Challis G . Analysis of the prodiginine biosynthesis gene cluster of Streptomyces coelicolor A3(2): new mechanisms for chain initiation and termination in modular multienzymes. Chem Biol. 2001; 8(8):817-29. DOI: 10.1016/s1074-5521(01)00054-0. View

19.

Lu Y, Liu D, Jiang R, Li Z, Gao X . Prodigiosin: unveiling the crimson wonder - a comprehensive journey from diverse bioactivity to synthesis and yield enhancement. Front Microbiol. 2024; 15:1412776. PMC: 11188435. DOI: 10.3389/fmicb.2024.1412776. View

20.

Williamson N, Simonsen H, Ahmed R, Goldet G, Slater H, Woodley L . Biosynthesis of the red antibiotic, prodigiosin, in Serratia: identification of a novel 2-methyl-3-n-amyl-pyrrole (MAP) assembly pathway, definition of the terminal condensing enzyme, and implications for undecylprodigiosin biosynthesis in.... Mol Microbiol. 2005; 56(4):971-89. DOI: 10.1111/j.1365-2958.2005.04602.x. View